Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuv...
Prof Ralf-Dieter Hofheinz - Uniklinik Mannheim, Mannheim, Germany
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer ( Prof Ralf-Dieter Hofheinz - Uniklinik Mannheim, Mannheim, Germany )
15 Jul 2019
Treating HER2-mutant advanced biliary tract cancer with neratinib
Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA
Treating HER2-mutant advanced biliary tract cancer with neratinib ( Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA )
15 Jul 2019
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients
Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan...
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients ( Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy )
15 Jul 2019
VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with local...
Dr Takayuki Yoshino - National Cancer Center Hospital East in Chiba, Japan
VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with locally advanced rectal cancer ( Dr Takayuki Yoshino - National Cancer Center Hospital East in Chiba, Japan )
15 Jul 2019
TRIBE2: Latest data for patients with mCRC
Dr Chiara Cremolini - Università di Pisa, Pisa, Italy
TRIBE2: Latest data for patients with mCRC ( Dr Chiara Cremolini - Università di Pisa, Pisa, Italy )
15 Jul 2019
Entrectinib in NTRK-fusion positive gastrointestinal cancers
Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy
Entrectinib in NTRK-fusion positive gastrointestinal cancers ( Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy )
15 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
Comment: POLO III trial for metastatic pancreatic cancer
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: POLO III trial for metastatic pancreatic cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
24 Jun 2019
Comment: Chemotherapy for frail and elderly patients with advanced gastroesophag...
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
13 Jun 2019
Comment: Laparoscopic versus open resection for colorectal liver metastases
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: Laparoscopic versus open resection for colorectal liver metastases ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
13 Jun 2019
CheckMate-142: Updated data from MSI high metastatic colon cancer patients
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
CheckMate-142: Updated data from MSI high metastatic colon cancer patients ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
13 Jun 2019
VOLFI trial final results: mFOLFOXIRI and panitumumab versus FOLFOXIRI in ECOG 0...
Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany
VOLFI trial final results: mFOLFOXIRI and panitumumab versus FOLFOXIRI in ECOG 0-1 and primarily non-resectable mCRC patients ( Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany )
10 Jun 2019